Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Neoplasms 1331Breast Neoplasms 688Carcinoma, Non-Small-Cell Lung 543Neoplasm Metastasis 437Lymphoma 435Leukemia, Myeloid, Acute 432Melanoma 402Prostatic Neoplasms 380Multiple Myeloma 366Lymphoma, Non-Hodgkin 356Ovarian Neoplasms 343Colorectal Neoplasms 333Precursor Cell Lymphoblastic Leukemia-Lymphoma 328Pancreatic Neoplasms 328Leukemia, Lymphocytic, Chronic, B-Cell 323Leukemia 282Lung Neoplasms 275Glioblastoma 267Unspecified Adult Solid Tumor, Protocol Specific 257Recurrence 254Lymphoma, Follicular 248Lymphoma, Large B-Cell, Diffuse 245Brain Neoplasms 232Lymphoma, Mantle-Cell 210Hodgkin Disease 193Carcinoma, Renal Cell 193Head and Neck Neoplasms 192Myelodysplastic Syndromes 187Glioma 172Burkitt Lymphoma 172

Interventions

navicixizumab 1Erlotinib Hydrochloride 1Azacitidine 1Antibodies, Bispecific 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Completed × Advanced Solid Tumor Malignancies × Clear all
NCT02298387 2020-08-11

A Phase 1 Study of OMP-305B83 in Subjects With Solid Tumors

Mereo BioPharma

Phase 1 Completed
71 enrolled
Other solid neoplasm

Advanced Solid Tumor Malignancies

NCT00996515 2013-05-01

A Phase 1 Protocol of 5-Azacytidine and Erlotinib in Advanced Solid Tumor Malignancies

New Mexico Cancer Research Alliance

Phase 1 Completed
30 enrolled
Other solid neoplasm

Advanced Solid Tumor Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡